Pfizer Vaccine Partner BioNTech Inks Cancer Deal

The company behind one of the most widely used vaccines against Covid-19, has agreed to acquire a U.S. manufacturing plant in a deal aimed at strengthening its core business of developing cutting-edge cancer therapies.

Apple, Amazon, Tesla Set to Post Results

More than a third of the S&P 500—including McDonald’s, Ford and...

Social-Media Manager, the Most Millennial Job, Comes of Age

Some social-media veterans have been doing their jobs for 15 years...

Chicago Casino Would Be Costly, Gambling Operators Say

Chicago is hoping a megacasino will aid its underfunded pensions but...

The Boss Wants You Back in the Office. Like, Now.

Companies are starting to summon workers back, though many employees have...